Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Non-Current Deffered Revenue (2016 - 2019)

Healthequity has reported Non-Current Deffered Revenue over the past 6 years, most recently at $3.0 million for Q1 2019.

  • Quarterly results put Non-Current Deffered Revenue at $3.0 million for Q1 2019, up 23.92% from a year ago — trailing twelve months through Jan 2019 was $3.0 million (up 23.92% YoY), and the annual figure for FY2019 was $3.0 million, up 23.92%.
  • Non-Current Deffered Revenue for Q1 2019 was $3.0 million at Healthequity, up from $2.5 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for HQY hit a ceiling of $3.0 million in Q1 2019 and a floor of $145000.0 in Q3 2015.
  • Median Non-Current Deffered Revenue over the past 5 years was $1.3 million (2016), compared with a mean of $1.3 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: crashed 66.67% in 2015 and later skyrocketed 642.07% in 2016.
  • Healthequity's Non-Current Deffered Revenue stood at $195000.0 in 2015, then skyrocketed by 564.1% to $1.3 million in 2016, then surged by 71.89% to $2.2 million in 2017, then increased by 10.78% to $2.5 million in 2018, then rose by 20.36% to $3.0 million in 2019.
  • The last three reported values for Non-Current Deffered Revenue were $3.0 million (Q1 2019), $2.5 million (Q2 2018), and $2.4 million (Q1 2018) per Business Quant data.